R Systems International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:37 pm

Quick Insight

R Systems International Ltd, operating in the IT Consulting & Software industry, currently trades at ₹433 with a market cap of ₹5,123 Cr. The stock carries a P/E ratio of 36.0, reflecting an optimistic investor sentiment. With a robust ROE of 21.2% and a competitive ROCE of 20.8%, the company demonstrates efficient capital utilization. However, the high P/BV ratio of 8.82x suggests the stock may be overvalued. It's noteworthy that the company maintains a healthy OPM of 16% and a comfortable ICR of 31.60x, indicating strong profitability and debt-servicing capabilities. Investors should keep a close watch on the company's growth trajectory to assess sustainability in the long term.

Competitors of R Systems International Ltd

All Competitor Stocks of R Systems International Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:01 am

Below is a detailed analysis of the quarterly data for R Systems International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 449.00 Cr. (Dec 2024) to 442.00 Cr., marking a decrease of 7.00 Cr..
• For Expenses, as of Mar 2025, the value is 372.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 378.00 Cr. (Dec 2024) to 372.00 Cr., marking a decrease of 6.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 71.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 71.00 Cr..
• For OPM %, as of Mar 2025, the value is 16.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 16.00%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Dec 2024) to 2.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Dec 2024) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 57.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 57.00 Cr..
• For Tax %, as of Mar 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 31.00% (Dec 2024) to 32.00%, marking an increase of 1.00%.
• For Net Profit, as of Mar 2025, the value is 39.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 39.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.26. The value appears to be declining and may need further review. It has decreased from 3.30 (Dec 2024) to 3.26, marking a decrease of 0.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:22 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:30 pm

Below is a detailed analysis of the balance sheet data for R Systems International Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Equity Capital, as of Dec 2024, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2023) which recorded 12.00 Cr..
• For Reserves, as of Dec 2024, the value is 612.00 Cr.. The value appears strong and on an upward trend. It has increased from 600.00 Cr. (Dec 2023) to 612.00 Cr., marking an increase of 12.00 Cr..
• For Borrowings, as of Dec 2024, the value is 73.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 131.00 Cr. (Dec 2023) to 73.00 Cr., marking a decrease of 58.00 Cr..
• For Other Liabilities, as of Dec 2024, the value is 519.00 Cr.. The value appears to be improving (decreasing). It has decreased from 572.00 Cr. (Dec 2023) to 519.00 Cr., marking a decrease of 53.00 Cr..
• For Total Liabilities, as of Dec 2024, the value is 1,216.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,315.00 Cr. (Dec 2023) to 1,216.00 Cr., marking a decrease of 99.00 Cr..
• For Fixed Assets, as of Dec 2024, the value is 571.00 Cr.. The value appears to be declining and may need further review. It has decreased from 627.00 Cr. (Dec 2023) to 571.00 Cr., marking a decrease of 56.00 Cr..
• For CWIP, as of Dec 2024, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2023) to 4.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Dec 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2023) which recorded 0.00 Cr..
• For Other Assets, as of Dec 2024, the value is 641.00 Cr.. The value appears to be declining and may need further review. It has decreased from 688.00 Cr. (Dec 2023) to 641.00 Cr., marking a decrease of 47.00 Cr..
• For Total Assets, as of Dec 2024, the value is 1,216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,315.00 Cr. (Dec 2023) to 1,216.00 Cr., marking a decrease of 99.00 Cr..

Notably, the Reserves (612.00 Cr.) exceed the Borrowings (73.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for R Systems International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Dec 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Dec 24, the value is 11.09. This value is within the healthy range. It has decreased from 11.84 (Dec 23) to 11.09, marking a decrease of 0.75.
• For Diluted EPS (Rs.), as of Dec 24, the value is 10.59. This value is within the healthy range. It has decreased from 11.84 (Dec 23) to 10.59, marking a decrease of 1.25.
• For Cash EPS (Rs.), as of Dec 24, the value is 16.61. This value is within the healthy range. It has increased from 16.48 (Dec 23) to 16.61, marking an increase of 0.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 52.75. It has decreased from 72.03 (Dec 23) to 52.75, marking a decrease of 19.28.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 52.75. It has decreased from 72.03 (Dec 23) to 52.75, marking a decrease of 19.28.
• For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 147.22. It has increased from 142.38 (Dec 23) to 147.22, marking an increase of 4.84.
• For PBDIT / Share (Rs.), as of Dec 24, the value is 22.42. This value is within the healthy range. It has increased from 22.30 (Dec 23) to 22.42, marking an increase of 0.12.
• For PBIT / Share (Rs.), as of Dec 24, the value is 16.90. This value is within the healthy range. It has decreased from 17.71 (Dec 23) to 16.90, marking a decrease of 0.81.
• For PBT / Share (Rs.), as of Dec 24, the value is 16.19. This value is within the healthy range. It has decreased from 16.95 (Dec 23) to 16.19, marking a decrease of 0.76.
• For Net Profit / Share (Rs.), as of Dec 24, the value is 11.09. This value is within the healthy range. It has decreased from 11.88 (Dec 23) to 11.09, marking a decrease of 0.79.
• For NP After MI And SOA / Share (Rs.), as of Dec 24, the value is 11.09. This value is within the healthy range. It has decreased from 11.84 (Dec 23) to 11.09, marking a decrease of 0.75.
• For PBDIT Margin (%), as of Dec 24, the value is 15.23. This value is within the healthy range. It has decreased from 15.66 (Dec 23) to 15.23, marking a decrease of 0.43.
• For PBIT Margin (%), as of Dec 24, the value is 11.47. This value is within the healthy range. It has decreased from 12.43 (Dec 23) to 11.47, marking a decrease of 0.96.
• For PBT Margin (%), as of Dec 24, the value is 10.99. This value is within the healthy range. It has decreased from 11.90 (Dec 23) to 10.99, marking a decrease of 0.91.
• For Net Profit Margin (%), as of Dec 24, the value is 7.53. This value is within the healthy range. It has decreased from 8.34 (Dec 23) to 7.53, marking a decrease of 0.81.
• For NP After MI And SOA Margin (%), as of Dec 24, the value is 7.53. This value is below the healthy minimum of 8. It has decreased from 8.31 (Dec 23) to 7.53, marking a decrease of 0.78.
• For Return on Networth / Equity (%), as of Dec 24, the value is 21.02. This value is within the healthy range. It has decreased from 22.91 (Dec 23) to 21.02, marking a decrease of 1.89.
• For Return on Capital Employeed (%), as of Dec 24, the value is 20.90. This value is within the healthy range. It has decreased from 22.13 (Dec 23) to 20.90, marking a decrease of 1.23.
• For Return On Assets (%), as of Dec 24, the value is 10.79. This value is within the healthy range. It has increased from 10.65 (Dec 23) to 10.79, marking an increase of 0.14.
• For Long Term Debt / Equity (X), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Dec 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Dec 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.09 (Dec 23) to 0.01, marking a decrease of 0.08.
• For Asset Turnover Ratio (%), as of Dec 24, the value is 1.38. It has decreased from 1.57 (Dec 23) to 1.38, marking a decrease of 0.19.
• For Current Ratio (X), as of Dec 24, the value is 2.26. This value is within the healthy range. It has increased from 1.70 (Dec 23) to 2.26, marking an increase of 0.56.
• For Quick Ratio (X), as of Dec 24, the value is 2.26. This value exceeds the healthy maximum of 2. It has increased from 1.70 (Dec 23) to 2.26, marking an increase of 0.56.
• For Dividend Payout Ratio (NP) (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 57.41 (Dec 23) to 0.00, marking a decrease of 57.41.
• For Dividend Payout Ratio (CP) (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 41.35 (Dec 23) to 0.00, marking a decrease of 41.35.
• For Earning Retention Ratio (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 42.59 (Dec 23) to 0.00, marking a decrease of 42.59.
• For Cash Earning Retention Ratio (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 58.65 (Dec 23) to 0.00, marking a decrease of 58.65.
• For Interest Coverage Ratio (X), as of Dec 24, the value is 31.60. This value is within the healthy range. It has increased from 29.48 (Dec 23) to 31.60, marking an increase of 2.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 16.63. This value is within the healthy range. It has decreased from 16.71 (Dec 23) to 16.63, marking a decrease of 0.08.
• For Enterprise Value (Cr.), as of Dec 24, the value is 5,556.69. It has decreased from 6,538.57 (Dec 23) to 5,556.69, marking a decrease of 981.88.
• For EV / Net Operating Revenue (X), as of Dec 24, the value is 3.19. This value exceeds the healthy maximum of 3. It has decreased from 3.88 (Dec 23) to 3.19, marking a decrease of 0.69.
• For EV / EBITDA (X), as of Dec 24, the value is 20.95. This value exceeds the healthy maximum of 15. It has decreased from 24.78 (Dec 23) to 20.95, marking a decrease of 3.83.
• For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 3.16. This value exceeds the healthy maximum of 3. It has decreased from 3.85 (Dec 23) to 3.16, marking a decrease of 0.69.
• For Retention Ratios (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 42.58 (Dec 23) to 0.00, marking a decrease of 42.58.
• For Price / BV (X), as of Dec 24, the value is 8.82. This value exceeds the healthy maximum of 3. It has decreased from 10.62 (Dec 23) to 8.82, marking a decrease of 1.80.
• For Price / Net Operating Revenue (X), as of Dec 24, the value is 3.16. This value exceeds the healthy maximum of 3. It has decreased from 3.85 (Dec 23) to 3.16, marking a decrease of 0.69.
• For EarningsYield, as of Dec 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Dec 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness